India Veterinary Medicine Manufacturing Market Research Report Information By Product (Drugs (Anti-infective, Anti-inflammatory, Parasiticide), Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines), Medicated Feed Additives (Amino Acids, Antibiotics)), By Animal Type (Companion Animals and Livestock Animals), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies, and Online Pharmacies)– India Market Forecast Till 2032

India Veterinary Medicine Manufacturing Market Overview

India Veterinary Medicine Manufacturing Market Size was valued at USD 0.82 Billion in 2022. The India Veterinary Medicine Manufacturing market industry is projected to grow from USD 0.89 Billion in 2023 to USD 1.74 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.80% during the forecast period (2023 - 2032). The growing number of animals being harmed by inflammatory illnesses and suffering, as well as rising pet adoption, are the main market drivers expected to drive the Indian market for India-made veterinary medicine manufacturing.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Veterinary Medicine Manufacturing Market Trends

• Growing trend for pet companions is driving the market growth

One of the main drivers of the Indian pet market's expansion is the rising number of pet parents. Furthermore, there has been an increase in the country's incidence of zoonotic illnesses, including nipah, trypanosomiasis, leptospirosis, cysticercosis, rabies, plague, toxoplasmosis, and kyasanur forest disease (KFD). Because of this, the Indian government has efficiently addressed the problem of livestock health and disease by implementing the centrally sponsored Livestock Health and Disease Control (LH&DC) system. In order to prevent brucellosis and foot and mouth disease (FMD), it has also started the National Animal Disease Control Programme (NADCP), which involves immunizing the population of pigs, sheep, goats, cattle, and buffalo.

Furthermore, this is having a beneficial impact on the market, as is the nation's rising intake of dairy and meat. In addition, a number of state governments are opening veterinary hospitals that are open around-the-clock to give agricultural and companion animals more care. Leading companies are also offering online veterinary consultations for animals all around India. The country's market is expanding due in part to the growing acceptance of the one health (OH) strategy, which is strategically gaining relevance among veterinarians and healthcare providers. The basic driver of the market expansion in India under investigation is the growing trend of pet adoption as well as the increase in the number of animals suffering from inflammatory and painful ailments. It is anticipated that the increasing number of veterinary clinics and hospitals in the area will support the veterinary pharmaceuticals market in India. This increase is explained by the increased need for veterinary hospitals and high-quality treatment for pets and animals.

India Veterinary Medicine Manufacturing Market Segment Insights

• India Veterinary Medicine Manufacturing Product Insights

The India Veterinary Medicine Manufacturing market segmentation, based on product, includes Drugs (Anti-infective, Anti-inflammatory, and Parasiticide), Vaccines (Inactivated Vaccines, Attenuated Vaccines, and Recombinant Vaccines), and Medicated Feed Additives (Amino Acids and Antibiotics). The medicated feed additives segment dominated the market mostly because feed additives with medicinal properties enhance the feed's nutritional value and quality. Animal growth and development are aided by these chemicals, which also boost feed intake. The use of medicated feed additives has increased as a result of growing consumer awareness of premium meat's high nutritious content.

• India Veterinary Medicine Manufacturing Animal Type Insights

The India Veterinary Medicine Manufacturing market segmentation, based on Animal Type, includes Companion Animals and Livestock Animals. The livestock animals category generated the most income. This is because the demand for animal products like meat, milk, and dairy products rises along with the global population, which makes it necessary to prevent and control disease as well as intensify livestock production. Furthermore, the livestock industry heavily utilizes medications.

Figure 1: India Veterinary Medicine Manufacturing Market, by Animal Type, 2022 & 2032 (USD Billion)

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Veterinary Medicine Manufacturing Route of Administration Insights

The India Veterinary Medicine Manufacturing market segmentation, based on Route of Administration, includes Oral, Parenteral, and Topical. The parenteral segment dominated the market mostly. Unlike oral drugs, parenteral drugs are digested differently and have a larger effect because they do not go through the digestive processes that oral medications do.

India Veterinary Medicine Manufacturing Distribution Channel Insights

The India Veterinary Medicine Manufacturing market segmentation, based on Distribution Channel, includes Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies, and Online Pharmacies. The Veterinary Hospital Pharmacies category generated the most income. These facilities are essential to the provision of veterinary care for animals, and they are ideally situated to include the use of veterinary medications in a wider range of treatments for both acute and chronic ailments.

India Veterinary Medicine Manufacturing Country Insights

Animal health in India is receiving more attention as a result of the rising demand for goods generated from animals, like dairy, eggs, and meat. Keeping animals healthy and productive requires the use of veterinary medications. The demand for veterinary drugs in India is driven by the growth of the animal agricultural industry, which includes aquaculture, dairy, and poultry. These medications are used by livestock farmers to treat and prevent illnesses in their animals as well as to ensure their general health. Preventive healthcare practices for animals are becoming more widely recognized. Veterinary medications are employed not only for the treatment of illnesses but also for immunization campaigns and other preventative measures. Veterinarian medications for companion animals are in higher demand as pet ownership becomes more popular. This covers immunizations, over-the-counter medications for common illnesses, and preventive care for animals in India.

India Veterinary Medicine Manufacturing Key Market Players & Competitive Insights

Leading market players are putting a lot of funds on R&D to broaden their product lines, which will fuel further growth in the India Veterinary Medicine Manufacturing market. In order to increase their presence, market players are also engaging in a range of strategic initiatives, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, India Veterinary Medicine Manufacturing industry must provide reasonably priced goods.

Major players in the India Veterinary Medicine Manufacturing market are engaging in research and development activities in an effort to boost market demand, including Ani Healthcare Pvt Ltd, Ashish Life Science Pvt Limited, Century Pharmaceuticals Ltd., GMT Pharma International, MarchVET, SSS Pharmachem Pvt. Ltd., Stanex Drugs and Chemicals Pvt Ltd, Vetbiochem India Private Limited, Virbac Animal Health India Pvt Ltd (Virbac), Zenley and Zovix Pharmaceuticals.

Key Companies in the India Veterinary Medicine Manufacturing market include

• Ani Healthcare Pvt Ltd


• Ashish Life Science Pvt Limited


• Century Pharmaceuticals Ltd.


• GMT Pharma International


• MarchVET


• SSS Pharmachem Pvt.Ltd.


• Stanex Drugs and Chemicals Pvt Ltd


• Vetbiochem India Private Limited


• Virbac Animal Health India Pvt Ltd (Virbac)


• Zenley and Zovix Pharmaceuticals

India Veterinary Medicine Manufacturing Industry Developments

October 2022: To safeguard the nation from economically important illnesses such as foot and mouth disease (FMD) and other developing ailments, Hyderabad-based Indian Immunologicals Limited (IIL) announced that it will invest roughly Rs 700 Crores to establish a new animal vaccine manufacturing facility in Genome Valley, Hyderabad, known as the "Vaccine Hub of the World."

December 2021: Recently, A'alda Vet India Pvt. Ltd. and Fujifilm India Pvt. Ltd., a leader in medical imaging and diagnostic technology, partnered to improve pet healthcare facilities. As part of the collaboration, DCC (Dogs, Cats, and Companions) animals will receive cutting-edge medical and screening equipment from Fujifilm India.

India Veterinary Medicine Manufacturing Market Segmentation

India Veterinary Medicine Manufacturing Product Outlook

• Drugs
  
  
  
  • Anti-infective
  
  
  • Anti-inflammatory
  
  
  • Parasiticide
  
  
  
  


• Vaccines
  
  
  
  • Inactivated Vaccines
  
  
  • Attenuated Vaccines
  
  
  • Recombinant Vaccines
  
  
  
  


• Medicated Feed Additives
  
  
  
  • Amino Acids
  
  
  • Antibiotics
  
  
  
  

India Veterinary Medicine Manufacturing Animal Type Outlook

•  Companion Animals


• Livestock Animals

India Veterinary Medicine Manufacturing Route of Administration Outlook

• Oral


• Parenteral


• Topical

India Veterinary Medicine Manufacturing Distribution Channel Outlook

• Veterinary Hospital Pharmacies


• Retail Veterinary Pharmacies


• Online Pharmacies